A Study to Evaluate the Antiviral Activity and Immune Response of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB)
Clinical trial NCT06993480 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06993480
- Sponsor
- Ausper Biopharma Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-15
- Primary completion
- 2027-07-27
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.